Prognosis and Treatment
-
Upload
karla-kalua -
Category
Documents
-
view
215 -
download
0
Transcript of Prognosis and Treatment
-
8/19/2019 Prognosis and Treatment
1/2
Prognosis and Treatment
Untreated shock is usually fatal. Even with treatment, mortality from cardiogenicshock after MI (60 to 65! and se"tic shock (#0 to $0! is high. %rognosis
de"ends on the cause, "ree&isting or com"licating illness, time 'etween onset and
diagnosis, and "rom"tness and adeuacy of thera"y.
General management
)irst aid involves kee"ing the "atient warm. E&ternal hemorrhage is controlled,
airway and ventilation are checked, and res"iratory assistance is given if
necessary. *othing is given 'y mouth, and the "atient+s head is turned to one side
to avoid as"iration if emesis occurs.
reatment 'egins simultaneously with evaluation. -u""lemental / 'y face mask
is "rovided. If shock is severe or if ventilation is inadeuate, airway intu'ation
with mechanical ventilation (see irway Esta'lishment and 1ontrol 2 racheal
Intu'ation! is necessary. wo large (3$4 to 364gauge! I catheters are inserted into
se"arate "eri"heral veins. central venous line or an intraosseous needle,
es"ecially in children, "rovides an alternative when "eri"heral veins cannot
"rom"tly 'e accessed (see also ascular ccess 2 Intraosseous Infusion!.
y"ically, 3 (or /0 m7kg in children! of 0.8 saline is infused over 35 min. Inma9or hemorrhage, :inger+s lactate is commonly used. Unless clinical "arameters
return to normal, the infusion is re"eated. -maller volumes (eg, /50 to 500 m!
are used for "atients with signs of high right4sided "ressure (eg, distention of neck
veins! or acute MI. fluid challenge should "ro'a'ly not 'e done in a "atient with
signs of "ulmonary edema. )urther fluid thera"y is 'ased on the underlying
condition and may reuire monitoring of 1% or %%. ;edside cardiac
ultrasonogra"hy to assess contractility and vena caval res"iratory varia'ility may
hel" determine the need for additional fluid vs the need for inotro"ic su""ort.
%atients in shock are critically ill and should 'e admitted to an I1U. Monitoring
includes E1
-
8/19/2019 Prognosis and Treatment
2/2
invasive alternative. -erial measurements of ;